Ciclesonide API

Name	Ciclesonide
Chinese name	环索奈德
Cas Number	126544-47-6
Source	Italy
Qualifications	USDMF/-/-/-/-

A new-generation corticosteroid anti-asthma drug developed by Sanofi-Aventis and Altana Pharmaceuticals in Germany, which can be positioned, activated, and inhaled. It is clinically mainly used to treat adults and children and adolescents over 4 years of age. Asthma and allergic rhinitis. Ciclesonide directly enters the lungs to achieve localized activation. It has many characteristics of an ideal inhaled corticosteroid, including high affinity with glucocorticoid receptors, better local anti-inflammatory activity and long-lasting effects, and complete first-pass effect The high binding rate with plasma protein is beneficial to better exert the efficacy and reduce systemic adverse reactions. Clinical data show better safety than other inhaled corticosteroids, including reduced local side effects and no cortisol inhibitory effect. Some patients believe that its effect is better than budesonide. Ciclesonide is another effective treatment option for asthma patients.

Hot Tags: ciclesonide api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Vardenafil API, Temozolomide API, Cinacalcet Hydrochloride API, Tavaborol API, Perindopril Arginine API, Active Pharmaceutical Ingredient

• Previous: Gadobutrol API
• Next: Aluminum Magnesium Plus API